← FDA DRUG APPROVALS

FDA ANDA · ANDA203859

MYCOPHENOLATE MOFETIL

Sponsor: MYLAN LABS LTD

APPLICATION
ANDA203859
TYPE
ANDA
ORIGINAL APPROVAL
2017-03-31
LATEST ACTION
2026-07-29
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

MYCOPHENOLATE MOFETIL HYDROCHLORIDEPrescription
MYCOPHENOLATE MOFETIL HYDROCHLORIDE 500MG/VIAL · INJECTABLE · INJECTION

Approval history

2026-07-29REMS · Supplement 17AP
2024-08-13REMS · Supplement 15AP
2023-03-08Labeling · Supplement 4 · standardAP
2023-03-08Labeling · Supplement 13 · standardAP
2023-03-08Labeling · Supplement 11 · standardAP
2021-08-11REMS · Supplement 9AP
2021-04-21REMS · Supplement 7AP
2021-01-15REMS · Supplement 3AP
2017-03-31UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →